Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MHRA
Pharma
In 'historic' nod, UK signs off on Vertex, CRISPR's gene therapy
Vertex and CRISPR have scored authorization in the U.K. for their exa-cel gene therapy to treat patients with sickle cell and beta thalassemia.
Kevin Dunleavy
Nov 16, 2023 11:45am
EU, UK authorities flag fake versions of Novo's Ozempic
Oct 19, 2023 10:15am
UK probes GLP-1 drugs' potential suicide risks: Reuters
Jul 26, 2023 11:38am
NICE signs off on reimbursement for Jazz's cannabinoid med
Feb 1, 2023 11:52am
Bayer's Nubeqa debuts in new use across the pond
Nov 28, 2022 10:34am
Hair today, gone tomorrow: Minoxidil drug sellers hit by MHRA
Oct 12, 2022 9:05am